Status:
COMPLETED
Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein
Lead Sponsor:
Spanish Foundation for Neurometrics Development
Collaborating Sponsors:
PronoKal Foundation
Child Health Foundation
Conditions:
ADD
ADHD
Eligibility:
All Genders
7-13 years
Phase:
EARLY_PHASE1
Brief Summary
Multicenter, Prospective, randomized, comparative and controlled study about the beneficial effects in behavior and brain connectivity of different dietary patterns in 100 children with ADHD between 7...
Detailed Description
The investigators collect electroencephalogram (EEG), event related potentials (ERP) data, and behavior parameters in ADD/ADHD children that not take stimulants or other drugs during study. They would...
Eligibility Criteria
Inclusion
- ADHD diagnosed 12 months before
- no take medication
- BMI above the 25th percentile
- Wiesel score between 80 and 100 (about 120)
- Patients who agree to participate and whose guardians signed the informed consent form
Exclusion
- eating disorders
- psychosis, bipolar disorder or depression
- kidney or liver failure
- diabetes
- diuretic or cortisone treatment
- haematological problems
- suprarenal diseases
- cancer
- Brain injury
- Cardiovascular or arrhythmia problems
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01856686
Start Date
December 1 2013
End Date
July 1 2014
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Remedies
Liverpool, Merseyside, United Kingdom, L1 0AH